Bio-Rad Laboratories | BIO - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
Abbott USD 10.46B 1.15B 2026-06
Agilent USD 1.43B 2M 2026-06
Becton, Dickinson and Co. USD 24.42B 283M 2026-06
Bio Techne USD 235.92M 5.5M 2026-03
Bio-Rad Laboratories USD 7.17B 322.6M 2026-06
Bruker USD 768.9M 44.3M 2026-06
Charles River Laboratories USD 2.84B 1.96B 2026-06
Danaher USD 52.58B 368M 2026-06
General Electric Aerospace USD 17.64B 417M 2026-06
Illumina USD 899M 47M 2026-06
IQVIA Holdings USD 1.77B 4.45B 2026-06
Laboratory Of America USD 3.27B 146.9M 2026-06
Merck USD 15.77B 2.4B 2026-06
Mettler Toledo International USD 739.77M 26.57M 2026-06
Myriad Genetics USD 212.8M 16.2M 2025-12
OraSure Technologies USD 40.35M 2.45M 2025-12
Pacific Biosciences Of California USD 97.83M 41.29M 2025-12
Quest Diagnostics USD 2.58B 88M 2026-06
Repligen USD 183M 8.72M 2026-06
Revvity USD 603.55M 24.8M 2026-06
Roche Holding CHF 18.9B 2.12B 2026-06
Siemens EUR 17.6B 531M 2026-06
Standard Biotools USD 30.56M 15.16M 2026-03
Thermo Fisher Scientific USD 9.81B 716M 2026-06
Tosoh JPY 242.99B 4.79B 2026-06
Waters USD 527M 592M 2026-06